Find your next paid study

National Human Genome Research Institute (NHGRI)NCT00359684

~$10 – $675

A Pilot Study to Assess Feasibility of Adipose Tissue Triglyceride (TG) Labelling in Familial Partial Lipodystrophy (FPLD)

Background: People with familial partial lipodystrophy (FPLD) do not store fat in the body normally. This can lead to serious illnesses such as diabetes and h…

Lipodystrophy

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NCT05996536

~$10 – $675

PROCPlatinum Resistant Ovarian CancerEndometrial Cancer

A Phase 1 First-in-Human Study of MUC16-Directed Antibody Drug Conjugate HWK-016 in Participants With Advanced Solid Tumors.

HWK-016-101 is a multicenter, open-label, first-in-human (FIH) Phase 1 study evaluating HWK-016, a targeted antibody-drug conjugate (ADC) in adult participants…

Whitehawk Therapeutics, Inc.NCT07470853

Human Papilloma VirusHuman Immunodeficiency VirusAnal Intraepithelial Neoplasia+1 more

Phase I Dose Escalation Study of the Use of ACU-D1, a Topical Proteasome Inhibitor in HPV Associated Vulvar and Perianal Lesions in People With HIV

The goal of this study is to test the maximum tolerated dose of ACU-D1 in HIV-positive people with HPV-associated vulvar and perianal lesions. The main questio…

Emory UniversityNCT06233331

~$10 – $6,250

Recurrent World Health Organization (WHO) Grade II GliomaLow-grade GliomaHigh-Grade Glioma (HGG)

PNOC021: A Phase I Trial Evaluating the Combination of Trametinib and Everolimus in Pediatric and Young Adult Patients With Recurrent Low-Grade Gliomas and High-Grade Gliomas

This phase I trial studies the side effects and best dose of trametinib and everolimus in treating pediatric and young adult patients with gliomas that have co…

University of California, San FranciscoNCT04485559

~$10 – $5,625

Positron Emission Tomography

NeuroFLiPP - Parametric PET of Neuroinflammation in Fatty Liver Disease

Alzheimer's Disease and related dementias (ADRD) affect about 6 million people in the U.S. and are the fifth leading cause of death for adults over 65. Recent …

University of California, DavisNCT06453915

~$10 – $6,250

Phase 2

A Two-stage Double-blind, Randomized, Placebo-controlled Study to Assess the Efficacy, Safety and Pharmacokinetics of Alpelisib in Pediatric and Adult Patients With Lymphatic Malformations Associated With a PIK3CA Mutation.

The main purpose of this study in participants with PIK3CA-mutated LyM is to assess the change in radiological response and symptom severity upon treatment wit…

Lymphatic Malformations

Novartis PharmaceuticalsNCT05948943

Phase 3

A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study To Evaluate The Efficacy And Safety Of DNTH103 In Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CAPTIVATE)

The purpose of this Phase 3 study is to demonstrate the efficacy of claseprubart (DNTH103) as compared to placebo in participants with chronic inflammatory dem…

Chronic Inflammatory Demyelinating Polyneuropathy

Dianthus TherapeuticsNCT06858579

Phase 2

Ketamine Oral Rinse in the Management of Oral Mucositis in Head and Neck Cancer Patients Undergoing Radiation Therapy

This 2-arm phase II study proposes to determine the efficacy of ketamine oral rinse in pain relief from mucositis in head and neck cancer patients undergoing r…

Head and Neck Cancer

University of OklahomaNCT06660017

~$10 – $6,250

LymphomaNon-Hodgkin LymphomaDiffuse Large B-Cell Lymphoma+1 more

Phase 1b/2 Study of Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Revlimid (ViPOR) in Relapsed/Refractory B-cell Lymphoma

Background: B-cell lymphoma is a cancer of white blood cells found in the lymph nodes. It affects the system that fights infections and disease. Researchers w…

National Cancer Institute (NCI)NCT03223610

~$10 – $5,625

Phase 3

A Phase 3, Randomized, Open-Label, Multicenter Study to Compare the Efficacy and Safety of Arlocabtagene Autoleucel (BMS-986393), a GPRC5D-directed CAR-T Cell Therapy, Versus Standard Regimens in Adult Participants With Relapsed or Refractory and Lenalidomide-exposed Multiple Myeloma

The purpose of this study is to compare the efficacy and safety of arlo-cel (BMS-986393) versus standard regimens in adult participants with Relapsed or Refrac…

Relapsed or Refractory Multiple Myeloma (RRMM)

Juno Therapeutics, Inc., a Bristol-Myers Squibb CompanyNCT06615479

Advanced Solid TumorsBreast Cancer RecurrentOvarian Cancer+2 more

A Phase 1/2, Open-Label, Dose-Escalation and Expansion First-In-Human Study of ATX-295, an Oral Inhibitor of the Kinesin Motor Protein KIF18A, in Patients With Locally Advanced or Metastatic Solid Tumors, Including High-Grade Serous Ovarian Cancer

The goal of this study is to identify a safe and tolerated dose of the orally administered KIF18A inhibitor ATX-295. In addition, this study will evaluate the …